STOCK TITAN
  1. Home
  2. Sec-filings
  3. JCAP
  4. [Form 4] Jefferson Capital, Inc. Insider Trading Activity

[Form 4] Jefferson Capital, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Jefferson Capital, Inc. (JCAP) – Form 4 insider transaction filed 07/01/2025.

Investment vehicles managed by J.C. Flowers & Co. – principally J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P. – each a 10 % beneficial owner of JCAP, reported open-market sales on 06/27/2025 of a combined 8,708,911 common shares at $15.00 per share, an aggregate value of roughly $131 million.

  • J.C. Flowers IV L.P. sold 2,687,631 shares and now holds 13,492,856 shares indirectly.
  • JCF IV Coinvest JCAP L.P. sold 6,021,280 shares and now holds 30,228,952 shares indirectly.

The filing re-states the ownership chain: both funds are controlled by JCF Associates IV L.P., whose general partner is JCF Associates IV Ltd., ultimately controlled by founder J. Christopher Flowers. The groups disclaim beneficial ownership except for their pecuniary interest.

Investment take-away: A large holder reduced its stake by roughly 22 % (8.7 M shares) but still retains ~43.7 M shares. While no reason for the sale is provided, the scale and timing may signal profit-taking or portfolio rebalancing, potentially adding selling pressure and raising questions about future ownership intentions.

Jefferson Capital, Inc. (JCAP) – Comunicazione Form 4 di operazioni insider presentata il 01/07/2025.

Veicoli di investimento gestiti da J.C. Flowers & Co. – in particolare J.C. Flowers IV L.P. e JCF IV Coinvest JCAP L.P. – ciascuno detentore effettivo del 10% di JCAP, hanno segnalato vendite sul mercato aperto il 27/06/2025 per un totale combinato di 8.708.911 azioni ordinarie a 15,00 $ per azione, per un valore complessivo di circa 131 milioni di dollari.

  • J.C. Flowers IV L.P. ha venduto 2.687.631 azioni e ora detiene indirettamente 13.492.856 azioni.
  • JCF IV Coinvest JCAP L.P. ha venduto 6.021.280 azioni e ora detiene indirettamente 30.228.952 azioni.

La comunicazione ribadisce la catena di proprietà: entrambi i fondi sono controllati da JCF Associates IV L.P., il cui socio accomandatario è JCF Associates IV Ltd., a sua volta controllata dal fondatore J. Christopher Flowers. I gruppi declinano la titolarità effettiva, fatta eccezione per il loro interesse patrimoniale.

Considerazioni sull'investimento: Un grande azionista ha ridotto la sua partecipazione di circa il 22% (8,7 milioni di azioni), ma mantiene ancora circa 43,7 milioni di azioni. Pur non essendo fornita alcuna motivazione per la vendita, la portata e il tempismo potrebbero indicare una presa di profitto o un riequilibrio del portafoglio, potenzialmente aumentando la pressione di vendita e sollevando dubbi sulle intenzioni future di proprietà.

Jefferson Capital, Inc. (JCAP) – Presentación del Formulario 4 de transacción insider el 01/07/2025.

Vehículos de inversión gestionados por J.C. Flowers & Co. – principalmente J.C. Flowers IV L.P. y JCF IV Coinvest JCAP L.P. – cada uno con un 10% de propiedad beneficiaria en JCAP, reportaron ventas en el mercado abierto el 27/06/2025 de un total combinado de 8.708.911 acciones ordinarias a 15,00 $ por acción, con un valor agregado aproximado de 131 millones de dólares.

  • J.C. Flowers IV L.P. vendió 2.687.631 acciones y ahora posee indirectamente 13.492.856 acciones.
  • JCF IV Coinvest JCAP L.P. vendió 6.021.280 acciones y ahora posee indirectamente 30.228.952 acciones.

La presentación reafirma la cadena de propiedad: ambos fondos están controlados por JCF Associates IV L.P., cuyo socio general es JCF Associates IV Ltd., controlada en última instancia por el fundador J. Christopher Flowers. Los grupos niegan la propiedad beneficiaria excepto por su interés pecuniario.

Conclusión de inversión: Un gran accionista redujo su participación aproximadamente un 22% (8,7 millones de acciones), pero aún mantiene alrededor de 43,7 millones de acciones. Aunque no se proporciona razón para la venta, la magnitud y el momento pueden indicar toma de ganancias o reequilibrio de cartera, lo que podría aumentar la presión de venta y generar dudas sobre las intenciones futuras de propiedad.

Jefferson Capital, Inc. (JCAP) – 2025년 7월 1일 제출된 Form 4 내부자 거래 보고서.

J.C. Flowers & Co.가 관리하는 투자 차량들 – 주로 J.C. Flowers IV L.P.와 JCF IV Coinvest JCAP L.P. – 각각 JCAP의 10% 실질 소유자로, 2025년 6월 27일에 총 8,708,911주를 주당 15.00달러에 공개 시장에서 매도했으며, 총 가치는 약 1억 3,100만 달러에 달합니다.

  • J.C. Flowers IV L.P.는 2,687,631주를 매도했으며 현재 간접적으로 13,492,856주를 보유하고 있습니다.
  • JCF IV Coinvest JCAP L.P.는 6,021,280주를 매도했으며 현재 간접적으로 30,228,952주를 보유하고 있습니다.

보고서는 소유 구조를 다시 명시합니다: 두 펀드 모두 JCF Associates IV L.P.가 통제하며, 그 일반 파트너는 JCF Associates IV Ltd.이고, 궁극적으로 창립자 J. Christopher Flowers가 통제합니다. 그룹은 금전적 이익을 제외한 실질 소유권을 부인합니다.

투자 시사점: 대주주가 약 22% (870만 주)를 매도했으나 여전히 약 4,370만 주를 보유하고 있습니다. 매도 이유는 제공되지 않았으나, 규모와 시점으로 볼 때 이익 실현 또는 포트폴리오 재조정 신호일 수 있으며, 매도 압력을 높이고 향후 소유 의도에 대한 의문을 제기할 수 있습니다.

Jefferson Capital, Inc. (JCAP) – Déclaration Formulaire 4 d’opération d’initié déposée le 01/07/2025.

Les véhicules d’investissement gérés par J.C. Flowers & Co. – principalement J.C. Flowers IV L.P. et JCF IV Coinvest JCAP L.P. – chacun détenteur effectif de 10 % de JCAP, ont déclaré des ventes sur le marché ouvert le 27/06/2025 de 8 708 911 actions ordinaires au prix de 15,00 $ par action, pour une valeur totale d’environ 131 millions de dollars.

  • J.C. Flowers IV L.P. a vendu 2 687 631 actions et détient désormais indirectement 13 492 856 actions.
  • JCF IV Coinvest JCAP L.P. a vendu 6 021 280 actions et détient désormais indirectement 30 228 952 actions.

Le dépôt réaffirme la chaîne de propriété : les deux fonds sont contrôlés par JCF Associates IV L.P., dont le commandité est JCF Associates IV Ltd., lui-même contrôlé par le fondateur J. Christopher Flowers. Les groupes déclinent toute propriété bénéficiaire autre que leur intérêt pécuniaire.

Conclusion d’investissement : Un important détenteur a réduit sa participation d’environ 22 % (8,7 millions d’actions) mais conserve toujours environ 43,7 millions d’actions. Bien qu’aucune raison de la vente ne soit fournie, l’ampleur et le timing pourraient signaler une prise de bénéfices ou un rééquilibrage de portefeuille, ce qui pourrait accroître la pression vendeuse et soulever des questions sur les intentions futures de détention.

Jefferson Capital, Inc. (JCAP) – Form 4 Insider-Transaktion eingereicht am 01.07.2025.

Von J.C. Flowers & Co. verwaltete Investmentvehikel – hauptsächlich J.C. Flowers IV L.P. und JCF IV Coinvest JCAP L.P. – jeweils mit einem 10%igen wirtschaftlichen Eigentumsanteil an JCAP, meldeten Offenmarktverkäufe am 27.06.2025 von insgesamt 8.708.911 Stammaktien zu je 15,00 $, mit einem Gesamtwert von etwa 131 Millionen US-Dollar.

  • J.C. Flowers IV L.P. verkaufte 2.687.631 Aktien und hält nun indirekt 13.492.856 Aktien.
  • JCF IV Coinvest JCAP L.P. verkaufte 6.021.280 Aktien und hält nun indirekt 30.228.952 Aktien.

Die Meldung bestätigt die Eigentumskette: Beide Fonds werden von JCF Associates IV L.P. kontrolliert, dessen Komplementär JCF Associates IV Ltd. ist, die letztlich vom Gründer J. Christopher Flowers kontrolliert wird. Die Gruppen lehnen eine wirtschaftliche Eigentümerschaft außer ihrem finanziellen Interesse ab.

Investment-Fazit: Ein Großaktionär hat seinen Anteil um etwa 22 % (8,7 Mio. Aktien) reduziert, hält aber weiterhin rund 43,7 Mio. Aktien. Obwohl kein Verkaufsgrund angegeben wurde, könnten Umfang und Zeitpunkt auf Gewinnmitnahmen oder Portfolioanpassungen hindeuten, was zusätzlichen Verkaufsdruck erzeugen und Fragen zu zukünftigen Eigentumsabsichten aufwerfen könnte.

Positive
  • Entities still hold ~43.7 million shares, maintaining significant skin in the game and influence over Jefferson Capital.
Negative
  • Large insider sale of 8.7 million shares (~$131 M) may signal reduced confidence or portfolio rebalancing, creating potential share-price overhang.
  • Complex ownership structure and beneficial-ownership disclaimers could obscure true economic incentives for outside investors.

Insights

TL;DR: 10 % owner sold $131 M in JCAP stock, trimming but not exiting; modestly bearish signal.

The sale represents a meaningful divestiture—about one-fifth of JCF-managed holdings—at a fixed $15 price, implying either pre-arranged liquidity or price discipline. JCAP’s free float increases, which can improve liquidity but also create short-term overhang. The entities retain a controlling-like position (≈44 M shares), so governance influence persists. Absent accompanying news (earnings miss, strategic shift), the transaction leans negative because insiders typically have superior information; however, continued large ownership tempers the signal.

TL;DR: Significant insider sale could raise governance and alignment questions.

Multiple investment partnerships, all controlled by J. Christopher Flowers, executed the sales. The complex structure can obscure true economic exposure; nonetheless, Section 16 reporting confirms accountability. The disclaimers of beneficial ownership are standard but highlight potential divergence between voting and economic interests. Stake reduction may weaken alignment with minority shareholders if further selling occurs. Investors should monitor subsequent filings for additional disposition activity and any 13D/13G amendments that might signal a shift in strategic intent.

Jefferson Capital, Inc. (JCAP) – Comunicazione Form 4 di operazioni insider presentata il 01/07/2025.

Veicoli di investimento gestiti da J.C. Flowers & Co. – in particolare J.C. Flowers IV L.P. e JCF IV Coinvest JCAP L.P. – ciascuno detentore effettivo del 10% di JCAP, hanno segnalato vendite sul mercato aperto il 27/06/2025 per un totale combinato di 8.708.911 azioni ordinarie a 15,00 $ per azione, per un valore complessivo di circa 131 milioni di dollari.

  • J.C. Flowers IV L.P. ha venduto 2.687.631 azioni e ora detiene indirettamente 13.492.856 azioni.
  • JCF IV Coinvest JCAP L.P. ha venduto 6.021.280 azioni e ora detiene indirettamente 30.228.952 azioni.

La comunicazione ribadisce la catena di proprietà: entrambi i fondi sono controllati da JCF Associates IV L.P., il cui socio accomandatario è JCF Associates IV Ltd., a sua volta controllata dal fondatore J. Christopher Flowers. I gruppi declinano la titolarità effettiva, fatta eccezione per il loro interesse patrimoniale.

Considerazioni sull'investimento: Un grande azionista ha ridotto la sua partecipazione di circa il 22% (8,7 milioni di azioni), ma mantiene ancora circa 43,7 milioni di azioni. Pur non essendo fornita alcuna motivazione per la vendita, la portata e il tempismo potrebbero indicare una presa di profitto o un riequilibrio del portafoglio, potenzialmente aumentando la pressione di vendita e sollevando dubbi sulle intenzioni future di proprietà.

Jefferson Capital, Inc. (JCAP) – Presentación del Formulario 4 de transacción insider el 01/07/2025.

Vehículos de inversión gestionados por J.C. Flowers & Co. – principalmente J.C. Flowers IV L.P. y JCF IV Coinvest JCAP L.P. – cada uno con un 10% de propiedad beneficiaria en JCAP, reportaron ventas en el mercado abierto el 27/06/2025 de un total combinado de 8.708.911 acciones ordinarias a 15,00 $ por acción, con un valor agregado aproximado de 131 millones de dólares.

  • J.C. Flowers IV L.P. vendió 2.687.631 acciones y ahora posee indirectamente 13.492.856 acciones.
  • JCF IV Coinvest JCAP L.P. vendió 6.021.280 acciones y ahora posee indirectamente 30.228.952 acciones.

La presentación reafirma la cadena de propiedad: ambos fondos están controlados por JCF Associates IV L.P., cuyo socio general es JCF Associates IV Ltd., controlada en última instancia por el fundador J. Christopher Flowers. Los grupos niegan la propiedad beneficiaria excepto por su interés pecuniario.

Conclusión de inversión: Un gran accionista redujo su participación aproximadamente un 22% (8,7 millones de acciones), pero aún mantiene alrededor de 43,7 millones de acciones. Aunque no se proporciona razón para la venta, la magnitud y el momento pueden indicar toma de ganancias o reequilibrio de cartera, lo que podría aumentar la presión de venta y generar dudas sobre las intenciones futuras de propiedad.

Jefferson Capital, Inc. (JCAP) – 2025년 7월 1일 제출된 Form 4 내부자 거래 보고서.

J.C. Flowers & Co.가 관리하는 투자 차량들 – 주로 J.C. Flowers IV L.P.와 JCF IV Coinvest JCAP L.P. – 각각 JCAP의 10% 실질 소유자로, 2025년 6월 27일에 총 8,708,911주를 주당 15.00달러에 공개 시장에서 매도했으며, 총 가치는 약 1억 3,100만 달러에 달합니다.

  • J.C. Flowers IV L.P.는 2,687,631주를 매도했으며 현재 간접적으로 13,492,856주를 보유하고 있습니다.
  • JCF IV Coinvest JCAP L.P.는 6,021,280주를 매도했으며 현재 간접적으로 30,228,952주를 보유하고 있습니다.

보고서는 소유 구조를 다시 명시합니다: 두 펀드 모두 JCF Associates IV L.P.가 통제하며, 그 일반 파트너는 JCF Associates IV Ltd.이고, 궁극적으로 창립자 J. Christopher Flowers가 통제합니다. 그룹은 금전적 이익을 제외한 실질 소유권을 부인합니다.

투자 시사점: 대주주가 약 22% (870만 주)를 매도했으나 여전히 약 4,370만 주를 보유하고 있습니다. 매도 이유는 제공되지 않았으나, 규모와 시점으로 볼 때 이익 실현 또는 포트폴리오 재조정 신호일 수 있으며, 매도 압력을 높이고 향후 소유 의도에 대한 의문을 제기할 수 있습니다.

Jefferson Capital, Inc. (JCAP) – Déclaration Formulaire 4 d’opération d’initié déposée le 01/07/2025.

Les véhicules d’investissement gérés par J.C. Flowers & Co. – principalement J.C. Flowers IV L.P. et JCF IV Coinvest JCAP L.P. – chacun détenteur effectif de 10 % de JCAP, ont déclaré des ventes sur le marché ouvert le 27/06/2025 de 8 708 911 actions ordinaires au prix de 15,00 $ par action, pour une valeur totale d’environ 131 millions de dollars.

  • J.C. Flowers IV L.P. a vendu 2 687 631 actions et détient désormais indirectement 13 492 856 actions.
  • JCF IV Coinvest JCAP L.P. a vendu 6 021 280 actions et détient désormais indirectement 30 228 952 actions.

Le dépôt réaffirme la chaîne de propriété : les deux fonds sont contrôlés par JCF Associates IV L.P., dont le commandité est JCF Associates IV Ltd., lui-même contrôlé par le fondateur J. Christopher Flowers. Les groupes déclinent toute propriété bénéficiaire autre que leur intérêt pécuniaire.

Conclusion d’investissement : Un important détenteur a réduit sa participation d’environ 22 % (8,7 millions d’actions) mais conserve toujours environ 43,7 millions d’actions. Bien qu’aucune raison de la vente ne soit fournie, l’ampleur et le timing pourraient signaler une prise de bénéfices ou un rééquilibrage de portefeuille, ce qui pourrait accroître la pression vendeuse et soulever des questions sur les intentions futures de détention.

Jefferson Capital, Inc. (JCAP) – Form 4 Insider-Transaktion eingereicht am 01.07.2025.

Von J.C. Flowers & Co. verwaltete Investmentvehikel – hauptsächlich J.C. Flowers IV L.P. und JCF IV Coinvest JCAP L.P. – jeweils mit einem 10%igen wirtschaftlichen Eigentumsanteil an JCAP, meldeten Offenmarktverkäufe am 27.06.2025 von insgesamt 8.708.911 Stammaktien zu je 15,00 $, mit einem Gesamtwert von etwa 131 Millionen US-Dollar.

  • J.C. Flowers IV L.P. verkaufte 2.687.631 Aktien und hält nun indirekt 13.492.856 Aktien.
  • JCF IV Coinvest JCAP L.P. verkaufte 6.021.280 Aktien und hält nun indirekt 30.228.952 Aktien.

Die Meldung bestätigt die Eigentumskette: Beide Fonds werden von JCF Associates IV L.P. kontrolliert, dessen Komplementär JCF Associates IV Ltd. ist, die letztlich vom Gründer J. Christopher Flowers kontrolliert wird. Die Gruppen lehnen eine wirtschaftliche Eigentümerschaft außer ihrem finanziellen Interesse ab.

Investment-Fazit: Ein Großaktionär hat seinen Anteil um etwa 22 % (8,7 Mio. Aktien) reduziert, hält aber weiterhin rund 43,7 Mio. Aktien. Obwohl kein Verkaufsgrund angegeben wurde, könnten Umfang und Zeitpunkt auf Gewinnmitnahmen oder Portfolioanpassungen hindeuten, was zusätzlichen Verkaufsdruck erzeugen und Fragen zu zukünftigen Eigentumsabsichten aufwerfen könnte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
J.C. Flowers IV L.P.
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC,
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Jefferson Capital, Inc. / DE [ JCAP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/27/2025 S 2,687,631 D $15 13,492,856 I See Footnotes(1)(3)(4)
Common Stock 06/27/2025 S 6,021,280 D $15 30,228,952 I See Footnotes(2)(3)(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
J.C. Flowers IV L.P.
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC,
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JCF IV Coinvest JCAP L.P.
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JCF Associates IV L.P.
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
JCF Associates IV Ltd.
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Flowers J. Christopher
(Last) (First) (Middle)
C/O J.C. FLOWERS & CO. LLC
1301 AVENUE OF THE AMERICAS, 16TH FLOOR
(Street)
NEW YORK NY 10019
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Represents securities held directly by J.C. Flowers IV L.P.
2. Represents securities held directly by JCF IV Coinvest JCAP L.P.
3. The general partner of each of J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P. is JCF Associates IV L.P. The general partner of JCF Associates IV L.P. is JCF Associates IV Ltd. J. Christopher Flowers controls JCF Associates IV Ltd and thus may be deemed to control each entity directly or indirectly controlled by JCF Associates IV Ltd, including J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P.
4. The Reporting Persons disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
J.C. FLOWERS IV L.P., By: JCF Associates IV L.P., its general partner, By JCF Associates IV Ltd, its general partner, By: J. Christopher Flowers, Director 07/01/2025
JCF IV COINVEST JCAP L.P., By: JCF Associates IV L.P., its general partner, By: JCF Associates IV Ltd, its general partner, By: J. Christopher Flowers, Director 07/01/2025
JCF ASSOCIATES IV L.P., By: JCF Associates IV Ltd, its general partner, By: J. Christopher Flowers, Director 07/01/2025
JCF ASSOCIATES IV LTD, By: J. Christopher Flowers, Director 07/01/2025
J. CHRISTOPHER FLOWERS, By: /s/ J. Christopher Flowers 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How many Jefferson Capital (JCAP) shares did J.C. Flowers entities sell?

They disposed of 8,708,911 common shares on 06/27/2025.

At what price were the JCAP shares sold?

The reported sale price was $15.00 per share.

What stake do the J.C. Flowers entities still hold after the sale?

They collectively retain roughly 43.7 million shares of JCAP common stock.

Does the filing explain why the insider sold shares?

No. The Form 4 only discloses the transactions; it provides no rationale for the sale.

Who ultimately controls the selling entities?

All entities are indirectly controlled by J. Christopher Flowers through JCF Associates IV Ltd.
Stock JCAP logo
Jernigan Capital

NASDAQ:JCAP

JCAP Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends
#256 Top Loser

JCAP Latest News

Jun 25, 2025
Jefferson Capital Announces Pricing of Initial Public Offering
Dec 15, 2021
KKR Launches Self-Storage Investment Platform with Jonathan Perry

JCAP Latest SEC Filings

Jun 30, 2025
[Form 4] Jefferson Capital, Inc. Insider Trading Activity

JCAP Stock Data

1.20B
10.00M
Real Estate Development
Finance
Link
US
Memphis